Aldagen Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Durham NC United States (2000)
Status: Acquired by Nuo Therapeutics (2012)

Organization Overview

First Clinical Trial
2005
NCT00692926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree